Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002229. doi: 10.1002/14651858.CD002229.pub2
Methods Randomised controlled trial of 1 year of follow-up
Participants 60 post-menopausal women (mean age 59.4) with previous coronary artery disease
Interventions

  1. 17-beta-estradiol + Medroxyprogesterone acetate

  2. placebo

  3. Estrogen + Medroxyprogesterone acetate
Outcomes All causes of death
Major CV events
CV deaths
Revascularization procedures
Notes 23% Losses of follow-up
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate